Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by besttobeon Nov 03, 2023 9:16am
121 Views
Post# 35715435

HME article bid relief update....

HME article bid relief update....

BID RELIEF LANGUAGES TAKES ‘SIGNIFICANT STEP FORWARD’PROVIDERS URGED TO CALL THEIR SENATORS

WASHINGTON – Language that would extend the 75/25 blended Medicare reimbursement rate in non-bid areas through 2024 is included a draft of omnibus health care legislation in advance of a Senate Finance Committee mark-up session that could take place as early as next week. 

Inclusion in this initial draft of legislative language to be considered by the committee does not guarantee the 75/25 provisions from S. 1294 will,ultimately, pass into law, but it's a significant step forward in the legislative process, says AAHomecare in a bulletin. 

HME advocates in states with Senate Finance Committee members are urged to send an email to health care committee staffers this week with this message(in your own words, if possible): 

“Please support language from S. 1294 to extend the 75/25 blended Medicare reimbursement rate for DME through 2024 in upcoming Senate Finance Committee consideration of healthcare legislation (section 405 of related legislative discussion draft). This measure will help DME suppliers continue to provide cost-effective, patient-preferred home-based care and send a message to CMS that a longer-term, market-based solution is needed.” 

These states are represented by a senator on the Finance Committee: Colorado, Delaware, Idaho, Indiana, Iowa, Louisiana, Maryland, Massachusetts, Montana, New Hampshire, Nevada, New Jersey, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Washington, Wisconsin, Wyoming. 

AAHomecare recommends calling the senator’s office and asking for the name and email of the individual who handles health care issues; most offices will readily share that information. 


<< Previous
Bullboard Posts
Next >>